RTI Surgical (RTIX) Cash Flow Statement

Click line-items for a historical chart and %

Net income
Depreciation and amortization expense	4.39M
Amortization of deferred financing costs
Provision for bad debts and product returns	451K
Provision for inventory write-downs	2.05M
Amortization of deferred revenue
Deferred income tax provision (benefit)
Stock-based compensation	1.98M
Loss on asset abandonments
Accounts receivable	-1.67M
Inventories	-6.16M
Prepaid and other current assets
Other long-term assets
Accounts payable	-3.4M
Accrued expenses	-3.04M
Other long-term liabilities
Net cash provided by operating activities
Purchases of property, plant and equipment	-3.37M
Patent and acquired intangible asset costs	-804K
Net cash used in investing activities
Proceeds from exercise of common stock options	0
Net payments on short-term obligations
Proceeds from long-term obligations	8M
Payments on long-term obligations	-1.13M
Net cash used in financing activities
Effect of exchange rate changes on cash and cash equivalents	7K
Net increase in cash and cash equivalents	-1.13M
Cash and cash equivalents, beginning of period	12.75M
Cash and cash equivalents, end of period	11.62M

Entities mentioned with RTIX

View All Entities